| Expert‐based drug lists to measure anticholinergic burden: similar names, different results U Lertxundi, S DOMINGO‐ECHABURU, R Hernandez, J Peral, J Medrano Psychogeriatrics 13 (1), 17-24, 2013 | 107 | 2013 |
| Antidopaminergic therapy for managing comorbidities in patients with Parkinson’s disease U Lertxundi, J Peral, O Mora, S Domingo-Echaburu, ... American Journal of Health-System Pharmacy 65 (5), 414-419, 2008 | 44 | 2008 |
| Medication errors in Parkinson's disease inpatients in the Basque Country U Lertxundi, A Isla, MÁ Solinís, S Domingo-Echaburu, R Hernandez, ... Parkinsonism & related disorders 36, 57-62, 2017 | 41 | 2017 |
| Anticholinergic burden in Parkinson’s disease inpatients U Lertxundi, A Isla, MA Solinis, S Domingo-Echaburu, R Hernandez, ... European journal of clinical pharmacology 71, 1271-1277, 2015 | 41 | 2015 |
| Evaluación prospectiva de interacciones entre medicamentos en pacientes ingresados mediante una aplicación informática JP Aguirregoitia, UL Etxebarria, MJM Bengoechea, OM Atorrasagasti, ... Farmacia Hospitalaria 31 (2), 93-100, 2007 | 20 | 2007 |
| Estimación de la tasa de filtración glomerular para el ajuste posológico de los fármacos: reina la confusion J Peral-Aguirregoitia, U Lertxundi-Etxebarria, R Saracho-Rotaeche, ... Nefrología (Madrid) 32 (1), 115-117, 2012 | 16 | 2012 |
| Inappropriate antidopaminergic drug use in Parkinson's disease inpatients S Domingo-Echaburu, U Lertxundi, E Gonzalo-Olazabal, ... Current Drug Therapy 7 (3), 164-169, 2012 | 15 | 2012 |
| Comments on Duran et al.’s systematic review of anticholinergic risk scales (EJCP 2DOI 10.1007/s00228-013-1499-3) U Lertxundi, S Domingo-Echaburu, B Ruiz-Osante, ... European journal of clinical pharmacology 69, 1729-1729, 2013 | 14 | 2013 |
| Prospective assesment of drug interactions in hospitalized patients using a computer programme JP Aguirregoitia, UL Etxebarria, MJM Bengoechea, OM Atorrasagasti, ... FARMACIA HOSPITALARIA 31 (2), 93, 2007 | 13 | 2007 |
| Confusion regarding anticholinergic burden measurement U Lertxundi, S Domingo‐Echaburu, R Hernández, J Peral‐Aguirregoitia, ... Journal of the American Geriatrics Society 63 (5), 1054-1054, 2015 | 10 | 2015 |
| Comentarios a la versión en español de los criterios STOPP/START U Lertxundi, J Peral, R Hernández Rev. esp. geriatr. gerontol.(Ed. impr.), 170-171, 2011 | 10* | 2011 |
| lmmunophenotypic characterization of primary and secondary lymphoid follicles CP Luaces, JI Peral, M García Tejeiro, C Aguirre Histology and histopathology, 1988 | 7 | 1988 |
| Probable interaction between acenocoumarol and levofloxacin: a case series. I Palacios‐Zabalza, M Bustos‐Martínez, J Peral‐Aguirregoitia, ... Journal of Clinical Pharmacy & Therapeutics 40 (6), 2015 | 5 | 2015 |
| Estimating glomerular filtration rate in order to adjust drug doses: confusion abounds J Peral-Aguirregoitia, U Lertxundi-Etxebarria, R Saracho-Rotaeche, ... Nefrología (English Edition) 32 (1), 115-117, 2012 | 5 | 2012 |
| Antipsychotic induced symptomatic hyperprolactinemia: are dopamine agonists safe? U Lertxundi, S Domingo-Echaburu, J Peral, M García Psychopharmacology Bulletin 44 (3), 66, 2011 | 5 | 2011 |
| Beers 2015 Criteria: Aripiprazole in Parkinson′ s Disease U Lertxundi, S Domingo‐Echaburu, R Hernández, J Peral‐Aguirregoitia, ... Journal of the American Geriatrics Society 64 (4), 920-921, 2016 | 4 | 2016 |
| Monitorización por el Servicio de Farmacia de pacientes con potasio sérico alterado, relacionándolo con la función renal y la toma de fármacos que alteran el potasio AI Lambarri, MJM Bengoechea, AI Uranga, AS IBÁÑEZ, OI Olatz, ... Farmacia Hospitalaria 2002 (26/06), 335, 2002 | 4 | 2002 |
| Resultados de la intervención farmacéutica en la dosificación de zoledronato en función del aclaramiento de creatinina estimado OM Atorrasagasti, UL Etxeberria, JP Aguirregoitia, MJM Bengoechea Farmacia Hospitalaria 31 (5), 315-324, 2007 | 3 | 2007 |
| Pharmacotherapeutic Challenges in Parkinson's Disease Inpatients U Lertxundi, R Hernández, S Domingo-Echaburu, J Peral-Aguirregoitia, ... IntechOpen, 2016 | 2 | 2016 |
| Mechanism of clinically relevant drug-drug interactions detected by a semi-automatic method O Mora-Atorrasagasti, U Lertxundi-Etxebarria, J Peral-Aguirregoitia, ... EJHP PRACTICE 14 (5), 32-36, 2008 | 2 | 2008 |
